+44 (0) 20 3997 7634 | sales@fbkmed.com
Home > A phase II study of temsirolimus in previously treated advanced hepatocellular carcinoma (HCC).
31/05/14
Share on social media:
07/02/23
Bleepa Feedback Medical Feedback PLC
20/09/22
06/09/22